Low‐quality muscle mass rather than normal‐quality muscle mass determines fibrosis progression in biopsy‐proven NAFLD
出版年份 2023 全文链接
标题
Low‐quality muscle mass rather than normal‐quality muscle mass determines fibrosis progression in biopsy‐proven NAFLD
作者
关键词
-
出版物
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-05-30
DOI
10.1111/apt.17601
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Myosteatosis, but not Sarcopenia, Predisposes NAFLD Subjects to Early Steatohepatitis and Fibrosis Progression
- (2022) Yun-Cheng Hsieh et al. Clinical Gastroenterology and Hepatology
- Long-term effect of PNPLA3 on the aggravation of nonalcoholic fatty liver disease in the biopsy-proven cohort
- (2022) Bo Kyung Koo et al. Clinical Gastroenterology and Hepatology
- Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies
- (2022) Annalisa Cespiati et al. Biomedicines
- Prevalence trends of non-alcoholic fatty liver disease among young men in Korea: A Korean military population-based cross-sectional study
- (2022) Jaejun Lee et al. Clinical and Molecular Hepatology
- Nonalcoholic Fatty Liver Disease and Accelerated Loss of Skeletal Muscle Mass: A Longitudinal Cohort Study
- (2022) Dong Hyun Sinn et al. HEPATOLOGY
- Cut-off values of skeletal muscle index and psoas muscle index at L3 vertebra level by computerized tomography to assess low muscle mass
- (2021) Gülistan Bahat et al. CLINICAL NUTRITION
- Age-related changes in muscle quality and development of diagnostic cutoff points for myosteatosis in lumbar skeletal muscles measured by CT scan
- (2021) Hong-Kyu Kim et al. CLINICAL NUTRITION
- Updated systematic review and meta-analysis on diagnostic issues and the prognostic impact of myosteatosis: A new paradigm beyond sarcopenia
- (2021) Hyemin Ahn et al. AGEING RESEARCH REVIEWS
- Deep neural network for automatic volumetric segmentation of whole-body CT images for body composition assessment
- (2021) Yoon Seong Lee et al. CLINICAL NUTRITION
- KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
- (2021) Seong Hee Kang et al. Clinical and Molecular Hepatology
- Cardiovascular Outcomes of Obesity According to Menopausal Status: A Nationwide Population-Based Study
- (2021) Bo Kyung Koo et al. Endocrinology and Metabolism
- Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver disease
- (2020) Salvatore Petta et al. Clinical Gastroenterology and Hepatology
- Myosteatosis in the Context of Skeletal Muscle Function Deficit: An Interdisciplinary Workshop at the National Institute on Aging
- (2020) Rosaly Correa-de-Araujo et al. Frontiers in Physiology
- A Critical Appraisal of the Definition of Sarcopenia in Patients with Non-Alcoholic Fatty Liver Disease: Pitfall of Adjusted Muscle Mass by Body Weight
- (2020) Huiyul Park et al. Life-Basel
- Fatty liver is an independent risk factor for gallbladder polyps
- (2020) Dong-Won Ahn et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models
- (2020) Maxime Nachit et al. Journal of Cachexia Sarcopenia and Muscle
- Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
- (2020) Gwyneth Soon et al. Clinical and Molecular Hepatology
- Relationship between relative skeletal muscle mass and non-alcoholic fatty liver disease: A 7-year longitudinal study
- (2018) Gyuri Kim et al. HEPATOLOGY
- Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease
- (2018) Bo Kyung Koo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas
- (2018) Cynthia Stretch et al. PLoS One
- OUP accepted manuscript
- (2018) AGE AND AGEING
- Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis
- (2017) Bo Kyung Koo et al. JOURNAL OF HEPATOLOGY
- A multicenter study to define sarcopenia in patients with end-stage liver disease
- (2017) Elizabeth J. Carey et al. LIVER TRANSPLANTATION
- Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease
- (2016) S. Petta et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- What Is the CT Dose Report Sheet and Why Is It Useful?
- (2016) William F. Sensakovic et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011)
- (2016) Yong-ho Lee et al. HEPATOLOGY
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- Age-related differences in strain rate tensor of the medial gastrocnemius muscle during passive plantarflexion and active isometric contraction using velocity encoded MR imaging: Potential index of lateral force transmission
- (2014) Usha Sinha et al. MAGNETIC RESONANCE IN MEDICINE
- Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
- (2014) Julia Kozlitina et al. NATURE GENETICS
- Multi-parametric MRI characterization of healthy human thigh muscles at 3.0 T - relaxation, magnetization transfer, fat/water, and diffusion tensor imaging
- (2014) Ke Li et al. NMR IN BIOMEDICINE
- Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings
- (2010) Elizabeth M. Brunt et al. HEPATOLOGY
- Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease
- (2009) Vincent Wai-Sun Wong et al. HEPATOLOGY
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started